Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

The June DMT stroke PR was made Before the Ifenprodil Dartmoth research was known or the even more recent 'interim' IPF/CC data 'trends'.

See "FORWARD LOOKING STATEMENT"...

Now some math? I am assuming the CEO would want a R/S of 1/10 as compared to 1/50. "IF" needed. I and most others (you) are holding as the the exit chances were long ago after final COVID PRs.

News about the Ifenprodil 'Indications" AGN is pursuing will precede news about the psyc angle. IMO.

I am invested/hope/predict for positive meeting results and approvals of All the current FDA and MNRA applications. These May gather a outside attention.
Hopefully shareholders will not need to fully finance those Clinical Trials thru grants/partners. Properly handled AGN could avoid a R/S and have a minimal dilution Private Placement. Maybe...

I hope they proofread any PRs and include the experts at AGN.